½ÃÀ庸°í¼­
»óǰÄÚµå
1594025

ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀå : µð¹ÙÀ̽º À¯Çü, Àç·á, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Medical Imaging Phantoms Market by Device Type (CT Phantoms, MRI Phantoms, Nuclear Imaging Phantoms), Material (False Organ, Stimulating Devices), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 194 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀåÀº 2023³â¿¡ 1¾ï 8,861¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 2¾ï 112¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 6.72%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 2¾ï 9,744¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒÀº MRI, CT, X-¼±, ÃÊÀ½ÆÄ µî ´Ù¾çÇÑ ¿µ»ó ÃÔ¿µ ±â¹ýÀÇ Å×½ºÆ®, º¸Á¤ ¹× ±³À°¿¡ »ç¿ëµÇ´Â ÀÎü Á¶Á÷À» ¸ð¹æÇÑ Àΰø ¹°Ã¼ÀÔ´Ï´Ù. ±× Çʿ伺Àº ÀÇ·á ¿µ»ó Áø´ÜÀÇ Ç°Áú º¸Áõ, Àåºñ °ËÁõ, ÇÁ·ÎÅäÄÝ Ç¥ÁØÈ­, ±³À° ¹× ÈÆ·Ã¿¡ ´ëÇÑ ¿ªÇÒ¿¡¼­ ºñ·ÔµË´Ï´Ù. ÁÖ¿ä »ç¿ëó´Â Çмú ȯ°æ, ÀÇ·á ½Ã¼³, ¿¬±¸ ±â°üÀ̸ç, ÃÖÁ¾ »ç¿ëó´Â Áø´Ü¼¾ÅÍ, º´¿ø, »ý¹°ÀÇÇÐ ¿¬±¸¼Ò·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ¿µ»ó ó¸® ½Ã½ºÅÛÀÇ ±â¼ú ¹ßÀü, ¿¹¹æ ÀÇÇп¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¿µ»ó Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ ½ÃÀåÀÌ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. º¹ÀâÇÑ »ý¹°ÇÐÀû ±¸Á¶¸¦ ¸ð¹æÇϴ ÷´Ü ÆÒÅÒÀÇ °³¹ß, ¿µ»ó ¼Ö·ç¼Ç °­È­¸¦ À§ÇÑ AI¿ÍÀÇ ÅëÇÕ, ¿ø°ÝÀÇ·á ¼­ºñ½ºÀÇ È®´ë´Â ºñÁî´Ï½º ±âȸÀ̸ç, È¿°úÀûÀÎ º¸Á¤ ÅøÀÌ ÇÊ¿äÇÑ °íǰÁú ¿µ»ó °Ë»ç¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023³â] 1¾ï 8,861¸¸ ´Þ·¯
¿¹Ãø³â[2024³â] 2¾ï 112¸¸ ´Þ·¯
¿¹Ãø³â[2030³â] 2¾ï 9,744¸¸ ´Þ·¯
CAGR(%) 6.72%

ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ¿µ»ó ±â¼ú Çõ½Å, ÀÇ·áºñ ÁöÃâ Áõ°¡, Á¤È®ÇÑ ¿µ»óÀÌ ÇÊ¿äÇÑ ¸ÂÃãÇü ÀÇ·á·ÎÀÇ Àüȯ µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª °í°¡ÀÇ Ã·´Ü ÆÒÅÒ ºñ¿ë, ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ³·Àº ÀÎÁöµµ, ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© µîÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼Ç°ú ¸ÂÃãÇü ±³À°À» ÅëÇØ ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÔÀ¸·Î½á Áö¿ª ½ÃÀåÀÇ ÀáÀç·ÂÀ» À̲ø¾î³¾ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀÌ ÇÊ¿äÇÑ ºÐ¾ß·Î´Â ´Ù¾çÇÑ ¿µ»ó Áø´Ü¿¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¸ÖƼ¸ð´Þ ÆÒÅÒ °³¹ß, »óÈ£¿î¿ë¼º ÃËÁø, ³»±¸¼º Çâ»ó µîÀÌ ÀÖ½À´Ï´Ù. ģȯ°æÀûÀÌ°í »ýüÀûÇÕ¼ºÀÌ ³ôÀº Àç·áÀÇ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ¿Í ºñ¿ë Àý°¨À» ÅëÇÑ Á¢±Ù¼º È®´ë´Â ¸Å¿ì Áß¿äÇÑ Àü·«ÀÔ´Ï´Ù. ÀÌ ½ÃÀå¿¡¼­´Â ±³À° ±â°ü, Á¦Á¶¾÷ü, ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿ÍÀÇ °øµ¿ ¿¬±¸¸¦ ÅëÇØ ÆÒÅÒÀÇ Çõ½ÅÀûÀÎ Àϰý »ý»êÀ» ÃßÁøÇÏ´Â Ãß¼¼¸¦ º¼ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ Æ´»õ ½ÃÀåÀ» °ø·«Çϱâ À§Çؼ­´Â ±â¼ú ¹ßÀü°ú ±ÔÁ¦ º¯È­¿¡ ¹ÎøÇÏ°Ô ´ëÀÀÇÏ´Â ÇÑÆí, À̹Ì¡ ¼Ö·ç¼Ç¿¡ AI¿Í ¸Ó½Å·¯´×À» ÅëÇÕÇÏ´Â ¹æÇâÀ¸·ÎÀÇ ÀüȯÀ» Ȱ¿ëÇØ¾ß ÇÕ´Ï´Ù. ºñ¿ë, Á¢±Ù¼º, ±â¼ú µµÀÔ »çÀÌÀÇ ¿ªÇÐ °ü°è¸¦ ÀÌÇØÇÏ´Â °ÍÀº °æÀï ¿ìÀ§¸¦ È®º¸ÇϰíÀÚ ÇÏ´Â ¾÷°è ÁøÀÔÀڵ鿡°Ô ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³ÇÕ´Ï´Ù.

ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÉºÎÀü, ¸¸¼ºÄáÆÏº´ µî »ýȰ½À°üº´À¸·Î ÀÎÇÑ Áúº´ºÎ´ã Áõ°¡
    • È¿°úÀûÀÎ ¿µ»ó Áø´ÜÀ» À§ÇÑ Á¤È®ÇÑ º¸Á¤ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • Á¶±â Áø´Ü¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í »ç³» ±³Á¤ ±â¼ú¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒÀÇ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ÀÇ·á¿ë ¿µ»ó ó¸® ºÐ¾ß¿¡¼­ Çõ½ÅÀûÀÎ ÆÒÅÒÀÇ R&D Ȱµ¿¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
    • X¼± ÆÒÅÒ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå °úÁ¦
    • ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒÀÇ Á¤ºñ ÇÕº´Áõ Áõ°¡

Porter's Five Forces: ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀå °ø·«À» À§ÇÑ Àü·« Åø

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ ÅøÀÔ´Ï´Ù. PorterÀÇ Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇϱâ À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» º¸¿ÏÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ·Â ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ´ã°í ÀÖÀ¸¸ç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ¼¼ºÐÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÏ¿© °ø±Þ¾÷ü°¡ Ä¡¿­ÇÑ °æÀï¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º: ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀå¿¡¼­ ¼º°øÀ¸·Î °¡´Â ±æ Â÷Æ®

ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÎ¹®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ±â¼úÇϰí ÀÖ½À´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀå : µð¹ÙÀ̽º À¯Çüº°

  • ¼­·Ð
  • CT ÆÒÅÒ
  • MRI ÆÒÅÒ
  • ÇÙÀ̹Ì¡ ÆÒÅÒ
  • ÃÊÀ½ÆÄ ÆÒÅÒ
  • X¼±°ú Åõ½Ã ÆÒÅÒ

Á¦7Àå ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀå : Àç·áº°

  • ¼­·Ð
  • À§Àå±â(False Organ)
  • ÀÚ±Ø ±â±â

Á¦8Àå ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð
  • Çмú¿¬±¸±â°ü
  • Áø´Ü°ú Ç¥ÁؽÇÇè½Ç
  • º´¿ø
  • ÀÇ·á±â±â ±â¾÷

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀå

  • ¼­·Ð
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀå

  • ¼­·Ð
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á¿ë À̹Ì¡ ÆÒÅÒ ½ÃÀå

  • ¼­·Ð
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

¾ð±ÞµÈ ±â¾÷

  • Bartec Technologies Ltd.
  • Carville Limited
  • Computerized Imaging Reference Systems, Inc.
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Gold Standard Phantoms
  • Kyoto Kagaku Co. Ltd.
  • Leeds Test Objects Ltd.
  • Modus Medical Devices Inc.
  • PTW Freiburg GmbH
  • Pure Imaging Phantoms
  • Shimadzu Corp.
KSA 24.11.28

The Medical Imaging Phantoms Market was valued at USD 188.61 million in 2023, expected to reach USD 201.12 million in 2024, and is projected to grow at a CAGR of 6.72%, to USD 297.44 million by 2030.

Medical imaging phantoms are artificial objects that simulate human tissues used for testing, calibration, and training in various imaging modalities such as MRI, CT, X-ray, and ultrasound. Their necessity stems from their role in quality assurance, equipment validation, protocol standardization, and educational training in medical imaging. Key applications are in academic settings, healthcare facilities, and research institutions, with end-use extending into diagnostic centers, hospitals, and biomedical research labs. The market is fueled by increasing demand for diagnostic imaging due to the rising incidence of chronic diseases, technological advances in imaging systems, and growing awareness of preventive healthcare. Opportunities lie in the development of advanced phantoms that emulate complex biological structures, integration with AI for enhanced imaging solutions, and the expansion of telehealth services, amplifying the need for high-quality imaging tests that necessitate effective calibration tools.

KEY MARKET STATISTICS
Base Year [2023] USD 188.61 million
Estimated Year [2024] USD 201.12 million
Forecast Year [2030] USD 297.44 million
CAGR (%) 6.72%

Key growth influencers include innovation in imaging technologies, increasing healthcare expenditure, and a move towards personalized medicine requiring precise imaging. However, challenges such as high costs of advanced phantoms, limited awareness in developing regions, and stringent regulatory frameworks can restrain market growth. Addressing these through cost-effective solutions and targeted training can unlock regional market potentials. Areas ripe for innovation include developing multi-modal phantoms that can be used across various imaging types, fostering interoperability, and enhancing durability. Investment in R&D for eco-friendly, biocompatible materials and expanding accessibility through cost reduction are pivotal strategies. The market shows a trend towards collaborative research efforts with educational institutions, manufacturers, and healthcare providers to propel innovative batch production of phantoms.

Navigating this niche requires agility in responding to technological advancements and regulatory changes, while capitalizing on the shift towards AI and machine learning integration within imaging solutions. Understanding the dynamics between cost, access, and technology adoption will be crucial for industry players aiming to gain competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Imaging Phantoms Market

The Medical Imaging Phantoms Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing disease burden of lifestyle-associated disorders such as cardiac failure, chronic kidney disease
    • Rising demand for accurate calibration techniques for effective diagnostic imaging procedures
    • Growing demand for early diagnostic methods and growing need for in-house calibration techniques
  • Market Restraints
    • High cost of the medical imaging phantom
  • Market Opportunities
    • Increasing investment in R&D activities for innovative phantoms in medical imaging
    • Growing demand for X-Ray phantoms
  • Market Challenges
    • Increasing maintenance complications of medical image phantom

Porter's Five Forces: A Strategic Tool for Navigating the Medical Imaging Phantoms Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Imaging Phantoms Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Imaging Phantoms Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Imaging Phantoms Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Imaging Phantoms Market

A detailed market share analysis in the Medical Imaging Phantoms Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Imaging Phantoms Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Imaging Phantoms Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Imaging Phantoms Market

A strategic analysis of the Medical Imaging Phantoms Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Imaging Phantoms Market, highlighting leading vendors and their innovative profiles. These include Bartec Technologies Ltd., Carville Limited, Computerized Imaging Reference Systems, Inc., FUJIFILM Holdings Corporation, GE Healthcare, Gold Standard Phantoms, Kyoto Kagaku Co. Ltd., Leeds Test Objects Ltd., Modus Medical Devices Inc., PTW Freiburg GmbH, Pure Imaging Phantoms, and Shimadzu Corp..

Market Segmentation & Coverage

This research report categorizes the Medical Imaging Phantoms Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across CT Phantoms, MRI Phantoms, Nuclear Imaging Phantoms, Ultrasound Phantoms, and X-Ray & Fluoroscopy Phantoms.
  • Based on Material, market is studied across False Organ and Stimulating Devices.
  • Based on End-User, market is studied across Academic & Research Institutes, Diagnostic & Reference Laboratories, Hospitals, and Medical Device Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing disease burden of lifestyle-associated disorders such as cardiac failure, chronic kidney disease
      • 5.1.1.2. Rising demand for accurate calibration techniques for effective diagnostic imaging procedures
      • 5.1.1.3. Growing demand for early diagnostic methods and growing need for in-house calibration techniques
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the medical imaging phantom
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in R&D activities for innovative phantoms in medical imaging
      • 5.1.3.2. Growing demand for X-Ray phantoms
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing maintenance complications of medical image phantom
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Imaging Phantoms Market, by Device Type

  • 6.1. Introduction
  • 6.2. CT Phantoms
  • 6.3. MRI Phantoms
  • 6.4. Nuclear Imaging Phantoms
  • 6.5. Ultrasound Phantoms
  • 6.6. X-Ray & Fluoroscopy Phantoms

7. Medical Imaging Phantoms Market, by Material

  • 7.1. Introduction
  • 7.2. False Organ
  • 7.3. Stimulating Devices

8. Medical Imaging Phantoms Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Diagnostic & Reference Laboratories
  • 8.4. Hospitals
  • 8.5. Medical Device Companies

9. Americas Medical Imaging Phantoms Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Medical Imaging Phantoms Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Medical Imaging Phantoms Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bartec Technologies Ltd.
  • 2. Carville Limited
  • 3. Computerized Imaging Reference Systems, Inc.
  • 4. FUJIFILM Holdings Corporation
  • 5. GE Healthcare
  • 6. Gold Standard Phantoms
  • 7. Kyoto Kagaku Co. Ltd.
  • 8. Leeds Test Objects Ltd.
  • 9. Modus Medical Devices Inc.
  • 10. PTW Freiburg GmbH
  • 11. Pure Imaging Phantoms
  • 12. Shimadzu Corp.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦